Emil Lou: Strong Work From the Budding Pancreatic Cancer Genomics Consortium - OncoDaily
Oncodaily,
Emil Lou, Professor with Tenure at University of Minnesota, shared a post on LinkedIn about a recent article he and his…
SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multicenter, Retrospective Cohort Study.
Overview of attention for article published in Annals of Surgery, October 2025
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (86th percentile)
-
Good Attention Score compared to outputs of the same age and source (74th percentile)
Readers on
- mendeley
- 1 Mendeley